Share Radio catches up with Volition's CEO Cameron Reynolds

Cancer diagnostics company Volition announced its results today, and the company confirmed it made significant progress in 2016. The company’s Nu.Q test for Colorectal cancer won a ‘CE mark’ last year which proved that the test was accurate. A final logistics trial for the test is now underway in Denmark and Volition should start generating revenue for the first time this year. Cameron Reynolds, Volition’s CEO, explained to Ed Bowsher what else can we expect from the firm this year, especially as the company now expands outside Europe.